Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004506369 | SCV005005226 | pathogenic | Inborn genetic diseases | 2023-12-12 | criteria provided, single submitter | clinical testing | The c.3706C>T (p.Q1236*) alteration, located in exon 15 (coding exon 15) of the PKD1 gene, consists of a C to T substitution at nucleotide position 3706. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. This variant was not reported in population-based cohorts in the Genome Aggregation Database (gnomAD). This variant has been reported in at least one individual with polycystic kidney disease (Nigro, 2023; Mantovani, 2020; Carrera, 2016). Based on the available evidence, this alteration is classified as pathogenic. |